SciTech Development, Inc.
2 clinical trials · Sponsor
◉ Watch SciTech Development, Inc.
| Record | Firm | Date |
|---|---|---|
| Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer (NCT06922539) | SciTech Development, Inc. | 2025-12-11 |
| Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma (NCT04234048) | SciTech Development, Inc. | 2023-12-18 |
Track SciTech Development, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.